Denis Mogilenko receives Glenn Foundation for Medical Research grant
Dr. Mogilenko’s research focuses on functional changes in the immune system during aging.
Genotype-specific blood counts
Vanderbilt researchers report genotype-specific reference ranges to improve interpretation of laboratory blood results in African America
A new mechanism for lupus
Vanderbilt researchers describe a new mechanism for the most common form of lupus and suggest a new treatment approach to this autoimmune
Billing codes aid lupus diagnosis
April Barnado, MD, MSCI, and colleagues screened de-identified electronic health records (EHRs) that are linked to genotyped blood samples stored in Vanderbilt University Medical Center’s BioVU biobank.
Division faculty helping patients with undiagnosed diseases
VUMC, an original member institution of the NIH program, announced it is launching its own program, the Vanderbilt Undiagnosed Diseases Program (VUDP), which will operate alongside the NIH program. The VUDP goal is to expand services to many more patients who are living with the often-dire consequences of an undiagnosed disease.
Dr. Crofford receives President’s Award from Tennessee Rheumatology Society
Dr. Leslie Crofford was presented with the President’s Award at the 2023 meeting of the Tennessee Rheumatology Society.
Azathioprine Tests Pharmacogenetics in Rheumatology
A team of researchers, led by Cecilia Chung, M.D., an associate professor in the Division of Rheumatology at Vanderbilt University Medical Center, published a review in Clinical Rheumatology using azathioprine as a high-stakes example of how pharmacogenetics can help rheumatologists prescribe wisely and the potential of developing risk scores.